XT
PYXS icon

XTX Topco’s Pyxis Oncology PYXS Stock Holding History

XTX Topco’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Sell
200,096
-88,937
-31% -$134K 0.01% 2505
2025
Q4 		$332K Buy
289,033
+271,334
+1,533% +$957K 0.01% 1974
2025
Q3 		$39.3K Sell
17,699
-18,681
-51% -$26.9K ﹤0.01% 2211
2025
Q2 		$40K Buy
+36,380
New +$41K ﹤0.01% 2062
2025
Q1 		– Sell
-22,492
Closed -$35.1K – 2965
2024
Q4 		$35.1K Sell
22,492
-62,279
-73% -$180K ﹤0.01% 1956
2024
Q3 		$311K Buy
84,771
+48,481
+134% +$170K 0.02% 1154
2024
Q2 		$120K Sell
36,290
-29,572
-45% -$124K 0.01% 1376
2024
Q1 		$281K Buy
65,862
+45,303
+220% +$191K 0.04% 914
2023
Q4 		$37K Buy
+20,559
New +$35.2K 0.01% 1286
2023
Q3 		– Sell
-15,236
Closed -$39K – 1927
2023
Q2 		$39K Buy
+15,236
New +$48.3K 0.01% 1268

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's PYXS Position: Q1 2026 in Review

XTX Topco reduced its Pyxis Oncology (PYXS) stake by 31% in Q1 2026, selling an estimated $134K and leaving 200,096 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #2505.

XTX Topco first reported a position in PYXS in Q2 2023 and has held it in 10 quarters since. The position peaked at $332K in Q4 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • XTX Topco held 200,096 shares of Pyxis Oncology worth $292K as of Q1 2026.
  • XTX Topco sold 88,937 Pyxis Oncology shares in Q1 2026, an estimated $134K.
  • Pyxis Oncology made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2505 holding.
  • XTX Topco first reported a position in Pyxis Oncology in Q2 2023 and has held it in 10 quarters since.
  • XTX Topco's Pyxis Oncology position peaked at $332K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.